Gary Zammit, PhD, the President and CEO of Clinilabs Drug Development Corporation, has contributed to a scientific study evaluating the effect of daridorexant on sleep architecture in people with insomnia. The study examined the effects of daridorexant on hyperarousal-related features with results showing daridorexant reduced certain EEG features linked to hyperarousal. Daridorexant decreased the probability [...]

  Clinilabs Events Join us for two exciting events at the ASENT meeting! Gary K. Zammit, PhD will be participating in the ASENT Training in Clinical Trials course Panel of Successful Trialists before the ASENT meeting. Overview: This panel discussion will introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation [...]